CLSD insider transaction filings
Clearside Biomedical, Inc. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-02-24. Screen CLSD transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CLSD between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Clearside Biomedical, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-24 | 4 | Thorp Clay — Director | Purchase (P): 15,000 @ $0.92 | EDGAR |
| 2025-01-10 | 4 | Deignan Charles A. — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Chong Ngai Hang Victor — Chief Medical Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | LASEZKAY GEORGE M — CEO, Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-11-04 | 4 | Chong Ngai Hang Victor — Chief Medical Officer | Purchase (P): 36,500 @ $1 | EDGAR |
| 2024-06-24 | 4 | Chong Ngai Hang Victor — Chief Medical Officer | Purchase (P): 23,500 @ $1.06 | EDGAR |
| 2024-06-21 | 4 | Gibney Anthony S — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Croarkin Richard — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Humphries William D. — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Thorp Clay — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Hutson Nancy J — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | EDWARDS JEFFREY L — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | SHAFFER CHRISTY L — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | YERXA BENJAMIN R — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | YERXA BENJAMIN R — Director | Purchase (P): 7,813 @ $1.31 | EDGAR |
| 2024-04-19 | 4 | Gibney Anthony S — Director | Purchase (P): 6,710 @ $1.25 · Purchase (P): 93,290 @ $1.30 | EDGAR |
| 2024-04-16 | 4 | Gibney Anthony S — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Chong Ngai Hang Victor — CHIEF MEDICAL OFFICER | Purchase (P): 30,000 @ $1.60 | EDGAR |
| 2024-03-18 | 4 | Chong Ngai Hang Victor — CHIEF MEDICAL OFFICER | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | WHITMORE BRADFORD T — 10% owner | Purchase (P): 444,444 @ $1.35 · Purchase (P): 444,444 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Deignan Charles A. — Chief Financial Officer | Sale (S): 12,900 @ $1.28 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | LASEZKAY GEORGE M — CEO, Director | Sale (S): 18,000 @ $1.27 · Grant/award (A): 439,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Clearside Biomedical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-12-29 | 8-K | 1.03 — Bankruptcy or Receivership 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-08 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-11-25 | 8-K | 1.03 — Bankruptcy or Receivership 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2025-09-03 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-08-14 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-07-17 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CLSD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →